Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 18 Prostatic Neoplasms 4 Carcinoma, Intraductal, Noninfiltrating 3 Ovarian Neoplasms 2 Mouth Neoplasms 2 Lymphedema 2 Triple Negative Breast Neoplasms 1 Stomatitis 1 Stomach Neoplasms 1 Pancreatic Neoplasms 1 Pain 1 Oropharyngeal Neoplasms 1 Melanoma 1 Lymphoma, Follicular 1 Liver Neoplasms 1 Liver Diseases 1 Leukemia 1 Intractable Pelvic Cancer Pain 1 Inflammatory Breast Neoplasms 1 Fibrosis 1 Esophageal Neoplasms 1 Dupuytren Contracture 1 Complex Ovarian Cyst 1 Colorectal Neoplasms 1 Chronic Pain 1 Carcinoma, Medullary 1 Carcinoma, Hepatocellular 1 Carcinoma, Ductal, Breast 1 Cachexia 1 Breast Screening 1

Interventions

fludarabine phosphate 15 Cyclophosphamide 15 Peripheral Blood Stem Cell Transplantation 13 Cyclosporine 12 Whole-Body Irradiation 10 Filgrastim 10 Mycophenolic Acid 9 Busulfan 8 Antilymphocyte Serum 7 Radiotherapy 5 Methylprednisolone 5 Melphalan 5 Therapeutics 4 Psychiatric Rehabilitation 4 Methotrexate 4 Exercise 4 Etoposide 4 Cord Blood Stem Cell Transplantation 4 Blood Specimen Collection 4 fludarabine 3 Rituximab 3 Prednisone 3 Granulocyte Colony-Stimulating Factor 3 Dexamethasone 3 Aprepitant 3 Analgesia 3 plerixafor 2 Tacrolimus 2 Standard of Care 2 Ondansetron 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Lymphoma, Follicular × High-Energy Shock Waves × Clear all

NCT00987428 2025-11-20

EEPAB2

Assistance Publique - Hôpitaux de Paris

Phase NA Terminated

Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡